European Archives - Page 125 of 1097 - European Medical Journal

Mifepristone-Misoprostol Reduces Treatment Failure in Early Pregnancy Loss

The addition of mifepristone to misoprostol for medical management of early pregnancy loss significantly reduces the rate of treatment failure.

New Model Improves Prognosis for Merkel Cell Carcinoma

A recent study has shed light on improving the prognostication of Merkel cell carcinoma, a rare and aggressive form of skin cancer.

70% of Young People Recover From Long COVID Within 2 Years

A new study highlights the enduring effects of post-COVID-19 condition on children and young people.

Gastric Metaplasia Linked to 19-Fold Cancer Risk in Caucasian Populations

The 10-year study challenges previous assumptions about gastric cancer risks in Western populations, particularly among Caucasian Americans.

High Processed Food Intake Linked to Active Psoriasis Risk

Individuals with active psoriasis displayed a lower proportion of females and were more likely to be obese.

3D-Printed Skin Model Could Revolutionise Dermatology Research

Researchers have developed an advanced artificial skin model using 3D printing technology, offering a significant breakthrough for medical and cosmetic research.

AI-Enhanced Prostate Biopsies: Improving Precision and Efficiency

AI is revolutionising prostate cancer diagnostics by enhancing imaging accuracy and reducing interoperator variability.

Neighbourhood Disadvantage Tied to Worse Outcomes in Idiopathic Pulmonary Fibrosis

Living in disadvantaged neighbourhoods worsens lung function and raises mortality risk for idiopathic pulmonary fibrosis patients, especially those with milder disease, according to a new study.

Antipsychotics Linked to Worsening Behaviour in Long-Term Care Residents

Antipsychotics may worsen behavioral symptoms in long-term care residents, according to a large Canadian study. Researchers found a significant association between antipsychotic use and behavioral deterioration, urging caution in prescribing these medications.

contract

Dr Dietmar Berger appointed as Gilead’s next Chief Medical Officer

Dr Dietmar Berger is set to join Gilead Sciences as Chief Medical Officer on 2 January 2025 – succeeding Dr Merdad Parsey.